Advanced Biomaterials with Intrinsic Immunomodulation Effects for Cancer Immunotherapy
Small Methods · 2023
DOI: 10.1002/smtd.202201404 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Small Methods, 2023. Verfasst von Weizhi Chen und 2 weiteren Autor:innen. Beteiligte Einrichtung: MOE Key Laboratory of High Performance Polymer Materials and Technology and Department of Polymer Science and Engineering, College of Chemistry and C…. Hauptthemen laut MEDLINE: Biocompatible Materials, Neoplasms. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 182 Literaturangaben. Gefördert von: National Key R&D Program of China, Natural Science Foundation of China, Natural Science Foundation of Jiangsu Province.
Abstract (Originalsprache)
In recent years, tumor immunotherapy has achieved significant success in tumor treatment based on immune checkpoint blockers and chimeric antigen receptor T‐cell therapy. However, about 70–80% of patients with solid tumors do not respond to immunotherapy due to immune evasion. Recent studies found that some biomaterials have intrinsic immunoregulatory effects, except serve as carriers for immunoregulatory drugs. Moreover, these biomaterials have additional advantages such as easy functionalization, modification, and customization. In this review, the recent advances of these immunoregulatory biomaterials in cancer immunotherapy and their interaction with cancer cells, immune cells, and the immunosuppressive tumor microenvironment are summarized. Finally, the opportunities and challenges of immunoregulatory biomaterials used in the clinic and the prospect of their future in cancer immunotherapy are discussed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- MOE Key Laboratory of High Performance Polymer Materials and Technology and Department of Polymer Science and Engineering, College of Chemistry and Chemical Engineering, Jiangsu Key Laboratory for Nanotechnology, Nanjin…
ORCID-Profile: Xiqun Jiang
Förderung
- National Key R&D Program of China
- Natural Science Foundation of China
- Natural Science Foundation of Jiangsu Province
- Fundamental Research Funds for the Central Universities
- National Natural Science Foundation of China
Zitieren
APA
Chen, W., Li, C., & Jiang, X. (2023). Advanced Biomaterials with Intrinsic Immunomodulation Effects for Cancer Immunotherapy. Small Methods. https://doi.org/10.1002/smtd.202201404
Vancouver
Chen W, Li C, Jiang X. Advanced Biomaterials with Intrinsic Immunomodulation Effects for Cancer Immunotherapy. Small Methods. 2023. doi:10.1002/smtd.202201404
BibTeX
@article{Chen2023,
author = {Chen, Weizhi and Li, Cheng and Jiang, Xiqun},
title = {Advanced Biomaterials with Intrinsic Immunomodulation Effects for Cancer Immunotherapy},
journal = {Small Methods},
year = {2023},
doi = {10.1002/smtd.202201404}
}
EUVIMED